These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 35909285)
1. Machine Learning-based Virtual Screening for STAT3 Anticancer Drug Target. Wadood A; Ajmal A; Junaid M; Rehman AU; Uddin R; Azam SS; Khan AZ; Ali A Curr Pharm Des; 2022; 28(36):3023-3032. PubMed ID: 35909285 [TBL] [Abstract][Full Text] [Related]
2. Machine learning-based drug design for identification of thymidylate kinase inhibitors as a potential anti-Mycobacterium tuberculosis. Shahab M; Danial M; Duan X; Khan T; Liang C; Gao H; Chen M; Wang D; Zheng G J Biomol Struct Dyn; 2024 May; 42(8):3874-3886. PubMed ID: 37232453 [TBL] [Abstract][Full Text] [Related]
3. Machine Learning-Based Virtual Screening and Molecular Simulation Approaches Identified Novel Potential Inhibitors for Cancer Therapy. Shahab M; Zheng G; Khan A; Wei D; Novikov AS Biomedicines; 2023 Aug; 11(8):. PubMed ID: 37626747 [TBL] [Abstract][Full Text] [Related]
4. In Silico Prediction of New Inhibitors for Kirsten Rat Sarcoma G12D Cancer Drug Target Using Machine Learning-Based Virtual Screening, Molecular Docking, and Molecular Dynamic Simulation Approaches. Ajmal A; Danial M; Zulfat M; Numan M; Zakir S; Hayat C; Alabbosh KF; Zaki MEA; Ali A; Wei D Pharmaceuticals (Basel); 2024 Apr; 17(5):. PubMed ID: 38794122 [TBL] [Abstract][Full Text] [Related]
5. Prospective virtual screening combined with bio-molecular simulation enabled identification of new inhibitors for the KRAS drug target. Ajmal A; Alkhatabi HA; Alreemi RM; Alamri MA; Khalid A; Abdalla AN; Alotaibi BS; Wadood A BMC Chem; 2024 Mar; 18(1):57. PubMed ID: 38528576 [TBL] [Abstract][Full Text] [Related]
6. Identification of Drug Targets and Their Inhibitors in Ali H; Samad A; Ajmal A; Ali A; Ali I; Danial M; Kamal M; Ullah M; Ullah R; Kalim M Pharmaceuticals (Basel); 2023 Aug; 16(8):. PubMed ID: 37631039 [No Abstract] [Full Text] [Related]
7. Identification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validation. Szelag M; Czerwoniec A; Wesoly J; Bluyssen HA PLoS One; 2015; 10(2):e0116688. PubMed ID: 25710482 [TBL] [Abstract][Full Text] [Related]
8. Chemical probes that competitively and selectively inhibit Stat3 activation. Xu X; Kasembeli MM; Jiang X; Tweardy BJ; Tweardy DJ PLoS One; 2009; 4(3):e4783. PubMed ID: 19274102 [TBL] [Abstract][Full Text] [Related]
9. Identification of a natural product-like STAT3 dimerization inhibitor by structure-based virtual screening. Liu LJ; Leung KH; Chan DS; Wang YT; Ma DL; Leung CH Cell Death Dis; 2014 Jun; 5(6):e1293. PubMed ID: 24922077 [TBL] [Abstract][Full Text] [Related]
10. Using machine learning to improve ensemble docking for drug discovery. Chandak T; Mayginnes JP; Mayes H; Wong CF Proteins; 2020 Oct; 88(10):1263-1270. PubMed ID: 32401384 [TBL] [Abstract][Full Text] [Related]
11. Identification of novel NLRP3 inhibitors as therapeutic options for epilepsy by machine learning-based virtual screening, molecular docking and biomolecular simulation studies. Zulfat M; Hakami MA; Hazazi A; Mahmood A; Khalid A; Alqurashi RS; Abdalla AN; Hu J; Wadood A; Huang X Heliyon; 2024 Aug; 10(15):e34410. PubMed ID: 39170440 [TBL] [Abstract][Full Text] [Related]
12. Machine learning and molecular simulation-based protocols to identify novel potential inhibitors for reverse transcriptase against HIV infections. Shahab M; Zheng G; Bin Jardan YA; Bourhia M J Biomol Struct Dyn; 2024 Feb; ():1-14. PubMed ID: 38379294 [TBL] [Abstract][Full Text] [Related]
13. Identification of inhibitors for Agr quorum sensing system of Staphylococcus aureus by machine learning, pharmacophore modeling, and molecular dynamics approaches. Ramasamy M; Vetrivel A; Venugopal S; Murugesan R J Mol Model; 2023 Jul; 29(8):258. PubMed ID: 37468720 [TBL] [Abstract][Full Text] [Related]
14. A computer-aided drug design approach to discover tumour suppressor p53 protein activators for colorectal cancer therapy. PatrĂcio RPS; Videira PA; Pereira F Bioorg Med Chem; 2022 Jan; 53():116530. PubMed ID: 34861473 [TBL] [Abstract][Full Text] [Related]
16. Development and validation of consensus machine learning-based models for the prediction of novel small molecules as potential anti-tubercular agents. Wani MA; Roy KK Mol Divers; 2022 Jun; 26(3):1345-1356. PubMed ID: 34110578 [TBL] [Abstract][Full Text] [Related]
17. A combined drug discovery strategy based on machine learning and molecular docking. Zhang Y; Wang Y; Zhou W; Fan Y; Zhao J; Zhu L; Lu S; Lu T; Chen Y; Liu H Chem Biol Drug Des; 2019 May; 93(5):685-699. PubMed ID: 30688405 [TBL] [Abstract][Full Text] [Related]
18. MLASM: Machine learning based prediction of anticancer small molecules. Balaji PD; Selvam S; Sohn H; Madhavan T Mol Divers; 2024 Aug; 28(4):2153-2161. PubMed ID: 38554168 [TBL] [Abstract][Full Text] [Related]
19. Error Tolerance of Machine Learning Algorithms across Contemporary Biological Targets. Kaiser TM; Burger PB Molecules; 2019 Jun; 24(11):. PubMed ID: 31167452 [TBL] [Abstract][Full Text] [Related]
20. Deep Learning and Structure-Based Virtual Screening for Drug Discovery against NEK7: A Novel Target for the Treatment of Cancer. Aziz M; Ejaz SA; Zargar S; Akhtar N; Aborode AT; A Wani T; Batiha GE; Siddique F; Alqarni M; Akintola AA Molecules; 2022 Jun; 27(13):. PubMed ID: 35807344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]